CD19-TriCAR-T/SILK

BIOLOGICAL2 trials

Sponsors

Timmune Biotech Inc.

Conditions

LeukemiaNon-Hodgkin LymphomaNon-Hodgkin Lymphoma of Intestine

Early Phase 1

Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Timmune Biotech Inc.Non-Hodgkin Lymphoma

Start: 2019-01-05End: 2022-01-01Target: 12Updated: 2020-03-13

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Timmune Biotech Inc.Leukemia, Non-Hodgkin Lymphoma of Intestine

Start: 2019-03-21End: 2022-10-15Target: 12Updated: 2019-09-06